Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 12:01 PM
Ignite Modification Date: 2025-12-25 @ 11:57 AM
NCT ID: NCT02232061
Description: None
Frequency Threshold: 5
Time Frame: Within 6 months of qualifying event up to approximately 64 months
Study: NCT02232061
Study Brief: Long-term, Open-label, Multicenter Study Assessing Long-term Cardiovascular Risks
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Fingolimod Fingolimod 0.5mg/day tablets taken orally 0 None 2 6 4 6 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
LYMPHOPENIA SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA (22.1) View
BRONCHITIS VIRAL SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (22.1) View
BASAL CELL CARCINOMA SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA (22.1) View
ASTHMA SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (22.1) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
INFUSION RELATED REACTION SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (22.1) View
VITAMIN D DEFICIENCY SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA (22.1) View
BURSITIS SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (22.1) View
MUSCULAR WEAKNESS SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (22.1) View
TENDONITIS SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (22.1) View
HEADACHE SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (22.1) View
MULTIPLE SCLEROSIS RELAPSE SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (22.1) View
SCIATICA SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (22.1) View
ANXIETY SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (22.1) View
OROPHARYNGEAL PAIN SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (22.1) View
HOT FLUSH SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA (22.1) View
HAEMORRHOIDAL HAEMORRHAGE SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (22.1) View
TRICHOMONIASIS SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (22.1) View
HYPERPHAGIA SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA (22.1) View
LYMPHOPENIA SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA (22.1) View
HYPOTHYROIDISM SYSTEMATIC_ASSESSMENT Endocrine disorders MedDRA (22.1) View
PYREXIA SYSTEMATIC_ASSESSMENT General disorders MedDRA (22.1) View
NASOPHARYNGITIS SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (22.1) View
VIRAL PHARYNGITIS SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (22.1) View
FOLATE DEFICIENCY SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA (22.1) View
HYPERCHOLESTEROLAEMIA SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA (22.1) View
FACET JOINT SYNDROME SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA (22.1) View
PREGNANCY SYSTEMATIC_ASSESSMENT Pregnancy, puerperium and perinatal conditions MedDRA (22.1) View
INSOMNIA SYSTEMATIC_ASSESSMENT Psychiatric disorders MedDRA (22.1) View